SMMT logo

Summit Therapeutics Inc. (SMMT) Depreciation and amortization

annual D&A:

$89.00K-$1.96M(-95.66%)
December 31, 2024

Summary

  • As of today (August 31, 2025), SMMT annual depreciation & amortization is $89.00 thousand, with the most recent change of -$1.96 million (-95.66%) on December 31, 2024.
  • During the last 3 years, SMMT annual D&A has fallen by -$2.37 million (-96.37%).
  • SMMT annual D&A is now -97.61% below its all-time high of $3.73 million, reached on January 31, 2010.

Performance

SMMT Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSMMTincome statement metrics

quarterly D&A:

$38.90K+$13.90K(+55.60%)
June 30, 2025

Summary

  • As of today (August 31, 2025), SMMT quarterly depreciation & amortization is $38.90 thousand, with the most recent change of +$13.90 thousand (+55.60%) on June 30, 2025.
  • Over the past year, SMMT quarterly D&A has increased by +$19.00 thousand (+95.48%).
  • SMMT quarterly D&A is now -94.43% below its all-time high of $697.80 thousand, reached on December 1, 2020.

Performance

SMMT quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSMMTincome statement metrics

TTM D&A:

$106.30K+$19.00K(+21.76%)
June 30, 2025

Summary

  • As of today (August 31, 2025), SMMT TTM depreciation & amortization is $106.30 thousand, with the most recent change of +$19.00 thousand (+21.76%) on June 30, 2025.
  • Over the past year, SMMT TTM D&A has dropped by -$1.13 million (-91.39%).
  • SMMT TTM D&A is now -95.80% below its all-time high of $2.53 million, reached on March 31, 2022.

Performance

SMMT TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSMMTincome statement metrics

SMMT Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-95.7%+95.5%-91.4%
3 y3 years-96.4%-93.0%-95.6%
5 y5 years-94.6%-90.8%-87.8%

SMMT Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-96.5%at low-93.7%+95.5%-95.6%+21.8%
5 y5-year-96.5%at low-94.4%+95.5%-95.8%+21.8%
alltimeall time-97.6%>+9999.0%-94.4%+241.2%-95.8%+800.9%

SMMT Depreciation and amortization History

DateAnnualQuarterlyTTM
Jun 2025
-
$38.90K(+55.6%)
$106.30K(+21.8%)
Mar 2025
-
$25.00K(+19.0%)
$87.30K(-2.2%)
Dec 2024
$89.00K(-95.7%)
$21.00K(-1.9%)
$89.30K(-86.1%)
Sep 2024
-
$21.40K(+7.5%)
$641.00K(-48.1%)
Jun 2024
-
$19.90K(-26.3%)
$1.23M(-27.3%)
Mar 2024
-
$27.00K(-95.3%)
$1.70M(-17.0%)
Dec 2023
$2.05M(-18.5%)
$572.70K(-6.8%)
$2.05M(-1.5%)
Sep 2023
-
$614.40K(+27.0%)
$2.08M(-0.4%)
Jun 2023
-
$483.80K(+29.0%)
$2.09M(-3.2%)
Mar 2023
-
$375.00K(-38.0%)
$2.15M(-10.0%)
Dec 2022
$2.51M(+2.4%)
$604.90K(-2.7%)
$2.39M(-0.8%)
Sep 2022
-
$621.90K(+12.7%)
$2.41M(+0.1%)
Jun 2022
-
$552.00K(-10.2%)
$2.41M(-4.8%)
Mar 2022
-
$615.00K(-1.6%)
$2.53M(+5.3%)
Dec 2021
$2.46M(+22.6%)
$625.30K(+0.8%)
$2.41M(-2.9%)
Sep 2021
-
$620.40K(-7.8%)
$2.48M(+5.4%)
Jun 2021
-
$673.20K(+38.2%)
$2.35M(+11.9%)
Mar 2021
-
$487.00K(-30.2%)
$2.10M(+1.9%)
Dec 2020
$2.00M(+22.3%)
-
-
Dec 2020
-
$697.80K(+41.5%)
$2.06M(+51.1%)
Sep 2020
-
$493.20K(+16.6%)
$1.36M(+56.6%)
Jun 2020
-
$423.00K(-5.7%)
$871.50K(+94.3%)
Mar 2020
-
$448.50K(+1679.8%)
$448.50K(-69.3%)
Dec 2019
$1.64M(+412.2%)
-
-
Jan 2019
-
$25.20K(-94.4%)
$1.46M(-10.8%)
Oct 2018
-
$451.00K(-3.6%)
$1.64M(+32.5%)
Jul 2018
-
$467.90K(-9.2%)
$1.23M(+51.4%)
Apr 2018
-
$515.30K(+155.9%)
$815.60K(+146.0%)
Jan 2018
$319.80K
-
-
DateAnnualQuarterlyTTM
Jan 2018
-
$201.40K(+302.0%)
$331.50K(+129.7%)
Oct 2017
-
$50.10K(+2.7%)
$144.30K(+27.7%)
Jul 2017
-
$48.80K(+56.4%)
$113.00K(+33.4%)
Apr 2017
-
$31.20K(+119.7%)
$84.70K(+17.5%)
Jan 2017
$77.30K(+5.9%)
-
-
Jan 2017
-
$14.20K(-24.5%)
$72.10K(-6.1%)
Oct 2016
-
$18.80K(-8.3%)
$76.80K(+0.8%)
Jul 2016
-
$20.50K(+10.2%)
$76.20K(+4.0%)
Apr 2016
-
$18.60K(-1.6%)
$73.30K(+2.8%)
Jan 2016
$73.00K(+35.2%)
-
-
Jan 2016
-
$18.90K(+3.8%)
$71.30K(+9.2%)
Oct 2015
-
$18.20K(+3.4%)
$65.30K(+11.6%)
Jul 2015
-
$17.60K(+6.0%)
$58.50K(+7.3%)
Apr 2015
-
$16.60K(+28.7%)
$54.50K(+9.7%)
Jan 2015
$54.00K(+32.7%)
-
-
Jan 2015
-
$12.90K(+13.2%)
$49.70K(+35.1%)
Oct 2014
-
$11.40K(-16.2%)
$36.80K(+44.9%)
Jul 2014
-
$13.60K(+15.3%)
$25.40K(+115.3%)
Apr 2014
-
$11.80K
$11.80K
Jan 2014
$40.70K(-72.4%)
-
-
Jan 2013
$147.70K(-50.9%)
-
-
Jan 2012
$300.90K(-56.5%)
-
-
Jan 2011
$692.00K(-81.4%)
-
-
Jan 2010
$3.73M(+10.1%)
-
-
Jan 2009
$3.39M(+2.6%)
-
-
Jan 2008
$3.30M(+373.2%)
-
-
Jan 2007
$698.10K(+185.4%)
-
-
Jan 2006
$244.60K(+2346.0%)
-
-
Jan 2005
$10.00K(>+9900.0%)
-
-
Jan 2004
$0.00
-
-

FAQ

  • What is Summit Therapeutics Inc. annual depreciation & amortization?
  • What is the all time high annual D&A for Summit Therapeutics Inc.?
  • What is Summit Therapeutics Inc. annual D&A year-on-year change?
  • What is Summit Therapeutics Inc. quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Summit Therapeutics Inc.?
  • What is Summit Therapeutics Inc. quarterly D&A year-on-year change?
  • What is Summit Therapeutics Inc. TTM depreciation & amortization?
  • What is the all time high TTM D&A for Summit Therapeutics Inc.?
  • What is Summit Therapeutics Inc. TTM D&A year-on-year change?

What is Summit Therapeutics Inc. annual depreciation & amortization?

The current annual D&A of SMMT is $89.00K

What is the all time high annual D&A for Summit Therapeutics Inc.?

Summit Therapeutics Inc. all-time high annual depreciation & amortization is $3.73M

What is Summit Therapeutics Inc. annual D&A year-on-year change?

Over the past year, SMMT annual depreciation & amortization has changed by -$1.96M (-95.66%)

What is Summit Therapeutics Inc. quarterly depreciation & amortization?

The current quarterly D&A of SMMT is $38.90K

What is the all time high quarterly D&A for Summit Therapeutics Inc.?

Summit Therapeutics Inc. all-time high quarterly depreciation & amortization is $697.80K

What is Summit Therapeutics Inc. quarterly D&A year-on-year change?

Over the past year, SMMT quarterly depreciation & amortization has changed by +$19.00K (+95.48%)

What is Summit Therapeutics Inc. TTM depreciation & amortization?

The current TTM D&A of SMMT is $106.30K

What is the all time high TTM D&A for Summit Therapeutics Inc.?

Summit Therapeutics Inc. all-time high TTM depreciation & amortization is $2.53M

What is Summit Therapeutics Inc. TTM D&A year-on-year change?

Over the past year, SMMT TTM depreciation & amortization has changed by -$1.13M (-91.39%)
On this page